Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nymble Health is a Vancouver-based digital health company that provides an AI-powered, text-based behavioral support platform for patients managing chronic metabolic conditions, specifically obesity and type 2 diabetes. Founded by frontline clinicians, the company bypasses traditional mobile apps in favor of frictionless, text-based communication via SMS and WhatsApp to deliver 24/7 personalized coaching, medication adherence support, and evidence-based guidance. Its modular suite of products includes nymble agent (conversational AI), nymble command (clinical oversight and risk engine), and nymble engage (structured outreach for pharmaceutical patient support programs). By integrating directly into existing healthcare workflows, Nymble Health helps clinics, pharmacies, and life sciences partners improve patient retention, reduce clinical burden, and track behavioral progress through its proprietary 'nymble score' metric.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nymble Health.